The application of molecular techniques to solid tumors

Seminars in Diagnostic Pathology

Volumn 19, Issue 2, 2002, Pages 94-103

  O'Connor, Sean L ^a   Cho, Jeong Hee ^a   McDonnell, Timothy J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cDNA arrays; Comparative genomic hybridization; Fluorescent in situ hybridization; Laser capture microscopy; Proteomics; Reverse transcription polymerase reaction; Serial analysis of gene expression; Single nucleotide polymorphisms; Tissue microarrays

Indexed keywords

DNA; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RNA;

CELL POPULATION; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN GENOME; LASER MICROSCOPY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR;

DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036247132     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
2. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
3. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
4. Chromosomal changes in locally recurrent, hormone-refractory prostate carcinomas by karyotyping and comparative genomic hybridization
5. Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization
6. Genetic alterations in hormone-refractory recurrent prostate carcinomas
7. Genetic changes in familial prostate cancer by comparative genomic hybridization
8. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer
9. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
10. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
11. Detection of gene amplification by genomic hybridization to cDNA microarrays
12. Genome-wide analysis of DNA copy-number changes using cDNA microarrays
13. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
14. The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: A comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data
15. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH)
16. Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy
17. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma
18. Tissue microarrays for high-throughput molecular profiling of tumor specimens
19. Molecular prediction of progression in patients with conservatively managed prostate cancer
20. Molecular characterization of minimal residual cancer cells in patients with solid tumors
21. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours
22. Gene expression analysis of prostate cancers
23. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis
24. Delineation of prognostic biomarkers in prostate cancer
25. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis
26. Monitoring signal transduction in cancer: cDNA microarray for semiquantitative analysis
27. Fixed and modifiable risk factors for breast cancer
28. The future of genetic studies of complex human diseases
29. An SNP map of the human genome generated by reduced representation shotgun sequencing
30. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms
31. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: Practice, problems and promise
32. Essay: Amersham Pharmacia Biotech & Science prize. Tantalizing transcriptomes - SAGE and its use in global gene expression analysis
33. Serial analysis of gene expression
34. Analysing uncharted transcriptomes with SAGE
35. The best of molecular biology
36. Gene expression profiles in normal and cancer cells
37. MicroSAGE: A modified procedure for serial analysis of gene expression in limited amounts of tissue
38. Serial microanalysis of renal transcriptomes
39. Serial analysis of gene expression in non-small cell lung cancer
40. A SAGE (serial analysis of gene expression) view of breast tumor progression
41. A public database for gene expression in human cancers
42. Analysis of human transcriptomes
43. Genes expressed in human tumor endothelium
44. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer
45. Identification and classification of p53-regulated genes
46. SAGE transcript profiles for p53-dependent growth regulation
47. A phosphatase associated with metastasis of colorectal cancer
48. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells
49. Secreted and cell surface genes expressed in benign and malignant colorectal tumors
50. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stein cells reveals mRNAs of multiple cell lineages
51. Comprehensive analyses of prostate gene expression: Convergence of expressed sequence tag databases, transcript profiling and proteomics
52. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer
53. Proteomic analysis of human prostate cancer
54. Cut out or poke in - The key to the world of single genes: Laser micromanipulation as a valuable tool on the look-out for the origin of disease
55. Single-cell mutation analysis of tumors from stained histologic slides
56. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast
57. Identification of expressed genes by laser-mediated manipulation of single cells
58. Laser capture microdissection
59. Laser capture microdissection and real-time reverse transcriptase/polymerase chain reaction of bronchiolar epithelium after bleomycin
60. Molecular profiling of clinical tissues specimens: Feasibility and applications
61. Laser capture micro-dissection-generated target sample for high-density oligonucleotide array hybridization
62. Laser micromanipulation systems as universal tools in cellular and molecular biology and in medicine
63. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis
64. Construction of a representative cDNA library from prostatic intraepithelial neoplasia
65. Laser capture microdissection comes into mainstream use
66. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia
67. Cancer proteomics: From biomarker discovery to signal pathway profiling
68. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
69. Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays
70. Gene-expression profiles in hereditary breast cancer
71. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
72. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: Combination analysis with cDNA expression array and tissue microarray
73. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques